Katz H R, Austen K F, Caterson B, Stevens R L
J Biol Chem. 1986 Oct 15;261(29):13393-6.
Rat serosal mast cells, which synthesize only heparin proteoglycans as detected by intrinsic labeling with [35S]sulfate, were analyzed for the presence of intracellular chondroitin sulfate proteoglycans by chemical and immunochemical means. Rat serosal mast cells of greater than 99% purity were treated with Zwittergent 3-12 and 4 M guanidine HCl, and the extracted nonradiolabeled proteoglycans were purified by density gradient centrifugation. As assessed by quantification of the unsaturated disaccharides released from the proteoglycans by chondroitinase ABC treatment, 10(6) rat serosal mast cells contained 2.4-4.5 micrograms of chondroitin sulfate proteoglycans. Analysis of the chondroitinase ABC digests by high performance liquid chromatography revealed the unsaturated disaccharides delta Di-4S, delta Di-diSB, and delta Di-diSE which were derived from GlcA----GalNAc-4-SO4, iduronic acid-2-SO4----GalNAc-4-SO4, and GlcA----GalNAc-4,6-diSO4, respectively. The molar ratio of the monosulfated to disulfated disaccharides was approximately 2:1 with delta Di-diSE greater than delta Di-diSB. When analyzed with a mouse anti-chondroitin sulfate monoclonal antibody and fluorescein-labeled F(ab')2 goat anti-mouse IgG, approximately 91% of permeabilized and chondroitinase ABC-treated cells in the mast cell preparations exhibited intracellular fluorescence, and the pattern of staining indicated that the chondroitin sulfate molecules were located in the secretory granules. The specificity of the monoclonal antibody for the unsaturated double bond created by chondroitinase ABC treatment of the proteoglycan in situ was established by the absence of fluorescence when the chondroitinase ABC step was omitted or when heparinase digestion was substituted for chondroitinase ABC. Furthermore, the ability of the anti-chondroitin sulfate monoclonal antibody to mediate fluorescence in situ was markedly reduced by absorption with solid-phase chondroitin sulfate proteoglycan that had been chondroitinase ABC-treated, but not by absorption with undigested proteoglycan or with solid-phase heparin. The highly sulfated chondroitin sulfate proteoglycans of rat serosal mast cells are the same type synthesized by the rat mucosal mast cell subclass.(ABSTRACT TRUNCATED AT 400 WORDS)
通过[35S]硫酸盐内在标记检测到仅合成肝素蛋白聚糖的大鼠浆膜肥大细胞,采用化学和免疫化学方法分析其细胞内硫酸软骨素蛋白聚糖的存在情况。用两性离子去污剂3 - 12和4M盐酸胍处理纯度大于99%的大鼠浆膜肥大细胞,提取的未标记蛋白聚糖通过密度梯度离心进行纯化。通过对硫酸软骨素酶ABC处理蛋白聚糖释放的不饱和二糖进行定量评估,10(6)个大鼠浆膜肥大细胞含有2.4 - 4.5微克硫酸软骨素蛋白聚糖。通过高效液相色谱分析硫酸软骨素酶ABC消化产物,发现了不饱和二糖δDi - 4S、δDi - diSB和δDi - diSE,它们分别来源于GlcA→GalNAc - 4 - SO4、艾杜糖醛酸 - 2 - SO4→GalNAc - 4 - SO4和GlcA→GalNAc - 4,6 - diSO4。单硫酸化与双硫酸化二糖的摩尔比约为2:1,δDi - diSE大于δDi - diSB。当用小鼠抗硫酸软骨素单克隆抗体和荧光素标记的F(ab')2山羊抗小鼠IgG进行分析时,肥大细胞制剂中约91%经通透处理和硫酸软骨素酶ABC处理的细胞呈现细胞内荧光,染色模式表明硫酸软骨素分子位于分泌颗粒中。当省略硫酸软骨素酶ABC步骤或用肝素酶消化替代硫酸软骨素酶ABC时,由于没有荧光,确定了单克隆抗体对蛋白聚糖原位经硫酸软骨素酶ABC处理产生的不饱和双键的特异性。此外,用经硫酸软骨素酶ABC处理的固相硫酸软骨素蛋白聚糖吸收后,抗硫酸软骨素单克隆抗体介导原位荧光的能力明显降低,但用未消化的蛋白聚糖或固相肝素吸收则不会降低。大鼠浆膜肥大细胞高度硫酸化的硫酸软骨素蛋白聚糖与大鼠黏膜肥大细胞亚类合成的是同一类型。(摘要截短至400字)